Daclizumab: all 55 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Efficacy and Safety of Daclizumab in Participants With RRMS Switching From NatalizumabTerminatedNCT02881567Phase 3Results posted
- A Study to Assess Immune Response in Pediatric Kidney Transplant Recipients Treated With Daclizumab (Zenapax)CompletedNCT02576145Phase 4Results posted
- Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019TerminatedNCT01797965Phase 3Results posted
- An Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple SclerosisCompletedNCT01462318Phase 3Results posted
- Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple SclerosisCompletedNCT01051349Phase 2Results posted
- Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor AntagonistsCompletedNCT00859131Not applicableResults posted
- Phase I/II Thymus Transplantation With Immunosuppression #950CompletedNCT00579527Phase 1/2Results posted
- Infliximab, Sirolimus and Daclizumab to Treat Age-Related Macular DegenerationCompletedNCT00304954Phase 2Results posted
- Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive CrossmatchCompletedNCT00275509Phase 3Results posted
- CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal TransplantationCompletedNCT00246129Phase 4Results posted
- Study Evaluating Sirolimus in Kidney Transplant RecipientsCompletedNCT00195273Phase 3Results posted
- Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C InfectionCompletedNCT00163657Phase 4Results posted
- Human Anti-Tac (Daclizumab) to Treat Juvenile Idiopathic Arthritis (JIA)-Associated UveitisCompletedNCT00130637Phase 2Results posted
- New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical TrialCompletedNCT00100178Phase 2Results posted
- A Study to Evaluate the Efficacy and Safety of Zenapax in Combination With CellCept, Cyclosporine, and Corticosteroids in Patients Undergoing Cardiac TransplantationCompletedNCT00048165Phase 4Results posted
- Islet Transplantation for Type 1 DiabetesCompletedNCT00014911Phase 2Results posted
- A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow FailureTerminatedNCT00001962Phase 2Results posted
- Anti-Tac for Treatment of LeukemiaCompletedNCT00001941Phase 1/2Results posted
- A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant ParticipantsCompletedNCT02554955Phase 4
- Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma PatientsCompletedNCT00847106Phase 1/2
- Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TXCompletedNCT00693524Phase 2
- Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Deceased Donor Renal TransplantationCompletedNCT00685061Phase 4
- Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological RiskCompletedNCT00682292Phase 3
- Thymoglobulin Versus Campath-1H Versus Daclizumab in Adult, Primary Living Donor Renal TransplantationCompletedNCT00681343Phase 4
- Chemotherapy, Radiation Therapy, and Vaccine Therapy With Basiliximab in Treating Patients With Glioblastoma Multiforme That Has Been Removed by SurgeryCompletedNCT00626015Phase 1
- Anti Cytokine Combination Therapy With Daclizumab and Infliximab for Treatment of Steroid Refractory Acute GVHDCompletedNCT00574470Phase 4
- B-Lymphocyte Immunotherapy in Islet TransplantationTerminatedNCT00468442Phase 2
- A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant RecipientsCompletedNCT00363116Phase 4
- Combination Daclizumab/Denileukin Diftitox to Treat UveitisCompletedNCT00326508Phase 2
- Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney TransplantationCompletedNCT00296348Phase 3
- Use of Daclizumab for the Prevention of Allograft Rejection in Pediatric Heart Transplant PatientsTerminatedNCT00284531Phase 1/2
- MMF, Daclizumab and Corticosteroids as Mainstay Immunosuppression in Renal Transplant PatientsCompletedNCT00231764Phase 4
- Prevention of Diabetes Progression Trial (PDPT)CompletedNCT00198146Phase 2
- The Use of Daclizumab and Anti-Thymocyte Globulin in Lung TransplantationCompletedNCT00181142Phase 2/3
- Study of Subcutaneous Daclizumab in Patients With Active, Relapsing Forms of Multiple SclerosisCompletedNCT00109161Phase 2
- Daclizumab to Treat HIV-Infected PatientsCompletedNCT00080431Phase 1
- Daclizumab and Sirolimus to Treat UveitisCompletedNCT00078689Phase 1
- Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative ColitisCompletedNCT00073047Phase 2
- A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)CompletedNCT00072969Phase 2
- Zenapax (Daclizumab) to Treat Relapsing Remitting Multiple SclerosisCompletedNCT00071838Phase 2
- Daclizumab to Treat Non-Infectious Sight-Threatening UveitisCompletedNCT00070759Phase 2
- Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I DiabetesCompletedNCT00064714Phase 2
- Methylprednisolone With or Without Daclizumab in Treating Patients With Acute Graft-Versus-Host DiseaseCompletedNCT00053976Phase 3
- To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis VulgarisCompletedNCT00050661Phase 1/2
- To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis VulgarisCompletedNCT00050648Phase 1/2
- Daclizumab to Treat Chronic Immune ThrombocytopeniaCompletedNCT00049725Phase 2
- A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant PatientsCompletedNCT00048152Phase 3
- Daclizumab Injections to Treat Non-Infectious Sight-Threatening UveitisCompletedNCT00043667Phase 2
- Daclizumab to Treat Wegener's GranulomatosisCompletedNCT00040248Phase 2
- Study of Daclizumab in Patients With Chronic, Persistent AsthmaCompletedNCT00028288Phase 2
- Pediatric Kidney Transplant Without Calcineurin InhibitorsCompletedNCT00023231Not applicable
- Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerCompletedNCT00006350Phase 2
- Zenapax to Treat Multiple SclerosisCompletedNCT00001934Phase 2
- HAT in Eye Complications of Behcet's DiseaseCompletedNCT00001865Phase 2
- ANTI-TAC THERAPY FOR UVEITISCompletedNCT00001526Phase 1